Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2021 2
2022 4
2024 1
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study.
Fourati S, Reslan A, Bourret J, Casalegno JS, Rahou Y, Chollet L, Pillet S, Tremeaux P, Dossou NC, Gault E, Salmona M, Imbert-Marcille BM, Mirand A, Larrat S, Moisan A, Marot S, Schnuriger A, Veyrenche N, Engelmann I, Handala L, Henry A, Stephan V, Brichler S, Avettand-Fenoel V, Zemali N, Lefeuvre C, Pronier C, Deroche L, Jaffar-Bandjee MC, Mouna L, Francois C, Regueme A, Hartard C, Rogez S, Gallais F, Ly A, Rodriguez C, Dos Santos G, Simon-Loriere E, Schwartz O, Buchrieser J, Pawlotsky JM, Lemoine F, Audureau E, Rameix-Welti MA; POLYRES investigators. Fourati S, et al. Among authors: veyrenche n. Lancet Infect Dis. 2025 Mar;25(3):301-311. doi: 10.1016/S1473-3099(24)00570-X. Epub 2024 Oct 14. Lancet Infect Dis. 2025. PMID: 39419046
Th17 CD4+ T-Cell as a Preferential Target for HIV Reservoirs.
Renault C, Veyrenche N, Mennechet F, Bedin AS, Routy JP, Van de Perre P, Reynes J, Tuaillon E. Renault C, et al. Among authors: veyrenche n. Front Immunol. 2022 Feb 7;13:822576. doi: 10.3389/fimmu.2022.822576. eCollection 2022. Front Immunol. 2022. PMID: 35197986 Free PMC article. Review.
Remdesivir for the Treatment of Human Coronavirus OC43 Encephalitis.
Fourgeaud J, Turlure P, Dupont M, Veyrenche N, Busquet C, Alain S, Leruez-Ville M, Dheilly NM, Frange P. Fourgeaud J, et al. Among authors: veyrenche n. J Med Virol. 2025 Mar;97(3):e70314. doi: 10.1002/jmv.70314. J Med Virol. 2025. PMID: 40108967 Free PMC article.
Kidney dysfunction and nephromegaly related to kidney Aichi virus infection.
Bartebin D, Buob D, Veyrenche N, Fourgeaud J, Frange P, Neven B, Aveline C, Thoreau B, Gauthier N, Boutboul D, El Karoui K. Bartebin D, et al. Among authors: veyrenche n. Kidney Int. 2025 Apr;107(4):762. doi: 10.1016/j.kint.2024.09.025. Kidney Int. 2025. PMID: 40118594 Free article. No abstract available.
Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019.
Bedin AS, Makinson A, Picot MC, Mennechet F, Malergue F, Pisoni A, Nyiramigisha E, Montagnier L, Bollore K, Debiesse S, Morquin D, Veyrenche N, Renault C, Foulongne V, Bret C, Bourdin A, Le Moing V, Van de Perre P, Tuaillon E. Bedin AS, et al. Among authors: veyrenche n. J Infect Dis. 2021 Feb 24;223(4):562-567. doi: 10.1093/infdis/jiaa724. J Infect Dis. 2021. PMID: 33206973 Free PMC article.
14 results